Price to Sales ratio Analysis of Pfizer Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY PS
Period Ending - Dec-24
Not Good PS
2.22
Period Ending - Dec-23
Not Good PS
2.40
Growth
-7.72 %
Trailing Twelve Months PS
Period Ending - Dec-24
Not Good PS
2.21
PS Analysis of Pfizer Inc
| PS Ratio of PFE has fallen by -7.72 % Compared to previous Financial Year. |
| PS Ratio with value of 3.30 was highest in Year Dec-20 in last Five Years. |
| PS Ratio with value of 1.39 was lowest in Year Dec-22 in last Five Years. |
| Latest PS Ratio with value of 2.22 is Greater than Average PS of 2.20 in last five years. |
Other PS Related Info of PFE that may interest you.
Pfizer Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| PFE | 24.76 | 24.67 | 0.365 % | Drug Manufacturers-General |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..
PS Related Ratios
| PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
| Good Value | |
FY - Historical Price to Sales of Pfizer Inc
| Period | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 |
|---|---|---|---|---|---|---|---|
| PS | 2.22 | 2.40 | 1.39 | 1.71 | 3.30 | 2.67 | 2.76 |
| Change | -7.72 % | 73.36 % | -18.98 % | -48.08 % | 23.40 % | -3.17 % | -3.36 % |
FY Chart of Price to Sales of Pfizer Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)